Genome-wide association studies in pharmacogenomics

被引：0
作者：
Ann K. Daly
机构：
[1] Ann K. Daly is at the Institute of Cellular Medicine,
[2] Newcastle University,undefined
[3] Newcastle upon Tyne NE2 4HH,undefined
[4] UK. a.k.daly@ncl.ac.uk,undefined
来源：
Nature Reviews Genetics | 2010年 / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The use of genome-wide association (GWA) approaches to identify variants that affect drug response or reaction is increasing rapidly, with at least 12 studies appearing in 2009 alone. This article reviews these pharmacogenomics GWA studies, and the prospects for this field.
引用
收藏
页码：241 / 246
页数：5
相关论文
共 73 条
  • [1] Meyer UA(2004)Pharmacogenetics — five decades of therapeutic lessons from genetic diversity Nature Rev. Genet. 5 669-676
  • [2] Daly AK(2009)Pharmacogenomics of anticoagulants: steps toward personal dosage Genome Med. 1 10-401
  • [3] Ge D(2009)Genetic variation in Nature 461 399-1104
  • [4] Suppiah V(2009) predicts hepatitis C treatment-induced viral clearance Nature Genet. 41 1100-1109
  • [5] Tanaka Y(2009) is associated with response to chronic hepatitis C interferon-a and ribavirin therapy Nature Genet. 41 1105-857
  • [6] Shuldiner AR(2009)Genome-wide association of JAMA 302 849-1027
  • [7] Cooper GM(2008) with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C Blood 112 1022-3768
  • [8] Takeuchi F(2009)Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy PLoS Genet. 5 e1000433-799
  • [9] Teichert M(2009)A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose Hum. Mol. Genet. 18 3758-819
  • [10] Link E(2008)A genome-wide association study confirms N. Engl. J. Med. 359 789-137
12345678